Dark

Check out our Dark Pool Levels

ASRT
Assertio Holdings, Inc. Common Stock
stock NASDAQ

Inactive

Jun 15, 2026

23.50USD+0.085%(+0.02)274,343

Pre-market

0.00USD-100.000%(-23.48)0

After-hours

0.00USD0.000%(0.00)0

OverviewOptionsHistoricalExchangesShortsNews

Jan 10, 2022

09:00AM EST Assertio Holdings, Inc. to Participate in the H.C. Wainwright GlobeNewswire Inc

Dec 16, 2021

08:20AM EST The Daily Biotech Pulse: Calliditas Snags FDA Nod, Novartis to Buy Back $15B In Shares, Valneva Touts Vaccine Data, Immix, Bionomics Debut On Wall Street Benzinga

Dec 15, 2021

05:35PM EST Assertio Holdings, Inc. Announces the Acquisition of GlobeNewswire Inc

Nov 12, 2021

04:05PM EST Assertio Holdings, Inc. Announces Preliminary Court Approval of GlobeNewswire Inc

Nov 5, 2021

09:43AM EDT The Daily Biotech Pulse: NRx's Zyesami Face Regulatory Rejection, Puma Slumps On Q3 Miss, Pfizer Has Good Tidings On Oral Antiviral COVID-19 Pill Benzinga

09:22AM EDT Assertio Therapeutics Q3 EPS $0.08 Beats $(0.04) Estimate, Sales $25.47M Beat $22.04M Estimate Benzinga

Nov 4, 2021

05:00AM EDT Earnings Scheduled For November 4, 2021 Benzinga

Oct 26, 2021

09:05AM EDT Assertio Holdings, Inc. (Assertio or the Company) (NASDAQ: ASRT) today announced that it will release third quarter 2021 financial results on Thursday, November 4, 2021, after the close of markets. Following the release of its financial results, Assertios management will host a conference call beginning at 4:30 p.m. eastern time. GlobeNewswire Inc

Oct 7, 2021

08:24AM EDT The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results Benzinga

Oct 6, 2021

07:33AM EDT The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal Benzinga

Oct 4, 2021

09:05AM EDT Assertio Holdings, Inc. (Assertio or the Company) (NASDAQ: ASRT) today announced that the Companys Chief Executive Officer, Dan Peisert, and Chief Financial Officer, Paul Schwichtenberg, will present and host individual meetings with investors at the following events: GlobeNewswire Inc

Sep 21, 2021

08:20AM EDT The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data Benzinga

Sep 10, 2021

07:36PM EDT Bausch Pays $300M For Diabetes Drug Lawsuit: Reuters Benzinga

Aug 20, 2021

07:45AM EDT The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data Benzinga

Aug 18, 2021

07:38AM EDT The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline Benzinga

Aug 17, 2021

08:28AM EDT The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business Benzinga

Aug 5, 2021

04:53PM EDT Assertio Holdings Raises FY21 Sales $85M-$92M To $91M-$96M Vs. $93.95M Est. Benzinga

04:52PM EDT Assertio Therapeutics Q2 EPS $(0.32) Up From $(1.40) YoY, Sales $24.83M Beat $24.26M Estimate Benzinga

08:08AM EDT The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO Benzinga

04:08AM EDT Earnings Scheduled For August 5, 2021 Benzinga

Aug 1, 2021

11:19AM EDT The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs Benzinga

Jul 28, 2021

07:33AM EDT The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal Benzinga

Jul 21, 2021

07:52AM EDT The Daily Biotech Pulse: J&J, Novartis Report Solid Results, Chembio Soars On COVID Test Order, Lumos Signals Clinical Trial Delay Benzinga

Jul 20, 2021

09:00AM EDT Assertio Holdings, Inc. (Assertio or the Company) (NASDAQ: ASRT) today announced that it will release second quarter 2021 financial results on Thursday, August 5, 2021, after the close of markets. Following the release of its financial results, Assertios management will host a conference call beginning at 4:30 p.m. eastern time. GlobeNewswire Inc

08:20AM EDT The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street Benzinga

Jul 16, 2021

07:37AM EDT The Daily Biotech Pulse: Moderna To Join S&P 500 Index, Thumbs Down For FibroGen's Anemia Drug, Corvus Shelves COVID Study Benzinga

Jun 4, 2021

09:28AM EDT Assertio Holdings Says Regains Compliance With Nasdaq Minimum Bid Price Requirement Benzinga

09:27AM EDT Assertio Holdings, Inc. Regains Compliance with Nasdaq Minimum Bid GlobeNewswire Inc

May 24, 2021

05:10PM EDT Assertio Form 4 Filings From Co. President, CEO, CFO and Chief Admin. Officer Show Purchase Of ~33.8K Shares On May 20, 2021 Benzinga

May 17, 2021

06:38AM EDT HEXO To Buy All Of 48North's Common Shares In An All-share Transaction RTTNews

06:36AM EDT Assertio Holdings Announces 1-for-4 Reverse Stock Split Benzinga

06:35AM EDT Assertio Files Certificate Of Amendment To Implement 1-to-4 Reverse Split RTTNews

06:32AM EDT Assertio Holdings, Inc. Announces 1-for-4 Reverse Stock Split GlobeNewswire Inc

06:30AM EDT - Adjournment Solely to Vote on the Reverse Split and Proportional Authorized Shares Reduction Proposal (Proposal 2) and Increase in Authorized Shares Proposal (Proposal 3) GlobeNewswire Inc

May 6, 2021

04:47PM EDT Assertio Therapeutics Q1 EPS $0.03 Beats $0.02 Estimate, Sales $26.84M Beat $24.33M Estimate; FY21 Net Product Sales $85M-$92M, Adj. EBITDA $34M-$40M Benzinga

04:17AM EDT Earnings Scheduled For May 6, 2021 Benzinga

May 5, 2021

09:08AM EDT Assertio Holdings Says Partners With Cove To Launch Direct To Patient Digital Campaign To Increase Accessibility Of CAMBIA And SPRIX Benzinga

09:00AM EDT Assertio Holdings, Inc. Partners with Cove, a Leading Migraine GlobeNewswire Inc

Apr 22, 2021

09:25AM EDT Assertio Holdings, Inc. (Assertio or the Company) (NASDAQ: ASRT) today announced that it will release first quarter 2021 financial results on Thursday, May 6, 2021, after the close of markets. Following the release of its financial results, Assertios management will host a conference call beginning at 4:30 p.m. eastern time. GlobeNewswire Inc

Apr 9, 2021

10:11AM EDT Benzinga's Top Ratings Upgrades, Downgrades For April 9, 2021 Benzinga

09:26AM EDT Gabelli & Co. Upgrades Assertio Holdings to Buy Benzinga

Mar 11, 2021

04:02PM EST Assertio Therapeutics Q4 EPS $(0.20) Down From $(0.14) YoY, Sales $29.80M Beat $27.65M Estimate Benzinga

04:01PM EST Full Year Net Product Sales of $93.5 Million; Full Year Pro-Forma Revenue of $119.2 Million in Line with Guidance GlobeNewswire Inc

03:35AM EST Earnings Scheduled For March 11, 2021 Benzinga

Mar 1, 2021

04:01PM EST Assertio Holdings, Inc. (Assertio or the Company) (NASDAQ: ASRT) today announced that Dan Peisert, President and Chief Executive Officer of Assertio, will present at and participate in investor meetings at the 33rd Annual Roth Conference, held virtually, on Monday, March 15, 2021. GlobeNewswire Inc

Feb 18, 2021

04:01PM EST Assertio Holdings, Inc. (Assertio or the Company) (NASDAQ: ASRT) today announced that it will release fourth quarter and full year 2020 financial results on Thursday, March 11, 2021, after the close of markets. Following the release of its financial results, Assertios management will host a conference call beginning at 4:30 p.m. eastern time. GlobeNewswire Inc

Feb 12, 2021

04:05PM EST Assertio Holdings, Inc. (Assertio or the Company) (NASDAQ: ASRT) today announced that it closed its previously announced registered direct of common stock at a purchase price of $0.98 per share for gross proceeds of approximately $34.3 million. GlobeNewswire Inc

Feb 10, 2021

07:34AM EST The Daily Biotech Pulse: Lilly COVID-19 Antibody Cocktail Approved for Emergency Use, Gamida, Genfit Jump On Data, 2 IPOs Benzinga

12:01AM EST Assertio Holdings, Inc. (Assertio or the Company) (NASDAQ: ASRT) today announced it has entered into a securities purchase agreement with certain institutional investors to purchase 35,000,000 shares of its common stock at a price of $0.98 per share, which is a premium to market based on applicable Nasdaq minimum price rules. GlobeNewswire Inc

Feb 9, 2021

04:05PM EST Assertio Holdings, Inc. (Assertio or the Company) (NASDAQ: ASRT) today announced that it closed its previously announced registered direct of common stock at a purchase price of $0.62 per share for gross proceeds of approximately $14.0 million. GlobeNewswire Inc

Feb 5, 2021

07:04AM EST Assertio Seeks To Raise $14M Via Equity At 21% Discount From Thursday's Close Benzinga

12:05AM EST Assertio Holdings, Inc. (Assertio or the Company) (NASDAQ: ASRT) today announced it has entered into a securities purchase agreement with certain institutional investors to purchase 22,600,000 shares of its common stock at a purchase price of $0.62 per share in a registered direct offering. GlobeNewswire Inc

Feb 4, 2021

07:22AM EST The Daily Biotech Pulse: Novartis COVID-19 Drug Readout, Merck And Roche Earnings, 3 IPOs Benzinga

06:13AM EST Assertio Holdings Now Expects To Recognize About $11M-$12M In Severance And Restructuring Charges In Q4 Of 2020 And Throughout 2021 Benzinga

Feb 3, 2021

04:33PM EST Assertio Announces $5M Insurance Settlement With Navigators Benzinga

04:01PM EST Assertio Holdings, Inc. (Assertio or the Company) (Nasdaq: ASRT) today announced that its subsidiary Assertio Therapeutics, Inc. (Assertio Therapeutics) entered into a Confidential Settlement Agreement and Mutual Release (the Settlement Agreement) with its primary product liability insurer, Navigators Specialty Insurance Company and Navigators Insurance Company (Navigators). GlobeNewswire Inc

Dec 29, 2020

04:06PM EST Assertio Reports Will Transfer Listing From Nasdaq Global Select Market To Nasdaq Capital Market; Co. Receives Added 180-Day Grace Period Until Jun. 28, 2021 To Regain Compliance Benzinga

04:05PM EST Company Receives additional 180-day grace period, until June 28, 2021, to satisfy the $1.00 bid price requirement to maintain Nasdaq listing GlobeNewswire Inc

Dec 15, 2020

09:14AM EST Assertio Plans Restructuring, To Cut Costs; Names Dan Peisert CEO RTTNews

09:10AM EST Assertio Outlines Restructuring Plan; Sees Total Annual Cost Reduced By ~$45M, Sees $8M-$10M In Charges Related To Restructuring Benzinga

09:00AM EST Assertio Holdings, Inc. (Assertio or the Company) (Nasdaq: ASRT) today announced a comprehensive restructuring plan designed to further reduce its cost base and right size its organization. GlobeNewswire Inc

Nov 10, 2020

04:01PM EST Assertio Holdings, Inc.(Assertio or the Company) (Nasdaq: ASRT), a commercial-stage pharmaceutical company, announced that President, chief executive officer and director,Todd Smith will present at and participate in investor meetings at theStifel2020Virtual HealthcareConference onNovember 17, 2020. The presentation will take placeat11:20 am ET GlobeNewswire Inc

Nov 6, 2020

02:45PM EST Stocks Trading Near 52-Week Lows On Friday, Nov. 6, 2020: ASRT, KBLMU, PNRG, YGMZ, APRE, UHT, LAIX, CLI, CORR, ANIP, CCOI, KBLM, NYC, UTL, PEI, TIG, EYEG, PVL, ZSAN, TTNP, NBRV, SFT, WPG, IFS, COGT, LMNL, PRFX, GBT, FNHC, ASMB, EPZM, UCL Benzinga

06:19AM EST Assertio Sees FY20 Sales Down 5% Year Over Year, Says Is Unable To Reconfirm EBITDA Margin Guidance At This Time Benzinga

06:19AM EST Assertio Therapeutics Q3 Adj. EBITDA $6.969M vs $34.336M In Same Qtr. Last Year, EPS $(0.09) Down From $0.05 YoY, Sales $34.56M Beat $32.50M Estimate Benzinga

06:00AM EST Assertio Reports Third Quarter 2020 Financial Results GlobeNewswire Inc

03:33AM EST Earnings Scheduled For November 6, 2020 Benzinga

Oct 23, 2020

08:00AM EDT Assertio to Release Third Quarter 2020 Financial Results and Host GlobeNewswire Inc

Sep 9, 2020

06:02AM EDT Assertio to Present at Cantor Virtual Global Healthcare Conference GlobeNewswire Inc

Aug 7, 2020

07:24AM EDT Recap: Assertio Holdings Q2 Earnings Benzinga

06:16AM EDT Assertio Therapeutics Q2 EPS $(0.35) Misses $(0.03) Estimate, Sales $20.62M Miss $25.33M Estimate Benzinga

06:02AM EDT Assertio Reports Second Quarter 2020 Financial Results GlobeNewswire Inc

04:02AM EDT Earnings Scheduled For August 7, 2020 Benzinga

Aug 6, 2020

03:50PM EDT Preview: Assertio Therapeutics's Earnings Benzinga

Jul 20, 2020

06:02AM EDT Assertio to Release Second Quarter 2020 Financial Results and Host GlobeNewswire Inc

Share